Payer Access Cell Therapy Director

Job Title

Director, Payer Access Cell Therapy (PACT)

Reports to:

VP US Head of Market Access
Department:
Commercial

Full Time

Location:

U.S., Remote

Autolus is a biopharmaceutical company, advancing innovative therapies at both clinical and commercial stages of development, focused on next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled, and highly active T cell therapies designed to better recognize cancer cells, break down their defence mechanisms, and eliminate these cells.

Autolus has a pipeline of product candidates in development for the treatment of haematological malignancies, solid tumours, and autoimmune diseases.

Our team is passionate in the pursuit of excellence and in pushing the boundaries of cancer therapy and autoimmune diseases to deliver life-changing treatments to patients. Whilst working at Autolus you will enjoy a flexible, diverse, and dynamic working environment which actively promotes creativity, leadership and teamwork. In addition to this Autolus is proud to offer a competitive salary, performance related bonus as well as private medical insurance, life assurance, pension and access to an employee share scheme.

Autolus promotes flexible working. Our Promise Autolus is developing complex, breakthrough therapies for a globally diverse market and equally recognises that diversity amongst our people is critical to our mission. As we draw on our differences, what we’ve experienced, and how we work, we celebrate diversity and are committed to creating an inclusive environment for all employees.

This role will be covering the Central/North East area. The Director, Payer Access Cell Therapy will be an integral member of the commercial organization, focused on operationalizing the overall Market Access strategy, and ensuring patients have timely access to Autolus therapies. The primary objective of the Director, Payer Access Cell Therapy is to secure robust coverage and reimbursement for all Autolus products through regional, national, and government payers.

In collaboration with center engagement and account management, this role will be integral to onboarding treatment centers and supporting broad timely patient access. The Director, Payer Access Cell Therapy will be a thought leader on all access related items including payer policy, pricing communication, and treatment center reimbursement.

• Identify, develop, and manage strategic relationships with National / Regional Commercial and Government payers within assigned geography.
• Implement approved pre-launch payer education plan to ensure awareness of Autolus pipeline and prepare the payer market for new cell therapy entrants.
• Present / provide approved product education and health economic information to key customers and communicate the value proposition of Autolus products.
• Assess payer and policy landscape to understand and plan for potential coverage of Autolus products for Commercial, Medicare and Medicaid patients, including policy legislation, payer class management, and advocacy.
• Obtain coverage for Autolus products within assigned accounts, while also identifying and mitigating potential challenges that may hinder access.
• Partner with Medical Affairs and Global Market Access team to address clinical and outcomes concerns from payers.
• Working knowledge of total cost of care and all aspects of reimbursement (coding, coverage, and payment) for inpatient and outpatient settings across payer segments.
• Understand payer requirements and hospital reimbursement for cell…